Clavido, Archie .

HRN: 12-84-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
AMPICILLIN 1GM (VIAL)
10/04/2025
10/11/2025
IVT
2g
Q6
Dengue
10/04/2025
CEFUROXIME 1.5GM (VIAL)
10/04/2025
10/06/2025
IVT
1.5GMS
1.5
NKA
Waiting Final Action 
10/04/2025
CEFUROXIME 500MG (TAB)
10/07/2025
10/14/2025
PO
500 MG
BID
NKA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: